David Egging

1.1k citations

22 papers · 723 indexed · h-index 14

Impact in

Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research

Papers in ⓘ

Immunology and Allergy 4
- Cell Adhesion Molecules Research 4
Radiology, Nuclear Medicine and Imaging 12
- Monoclonal and Polyclonal Antibodies Research 11
- Radiopharmaceutical Chemistry and Applications 2

Co-authors: Joost Schalkwijk (8 shared papers)Wim H.A. Dokter (6 shared papers)Ruud Ubink (8 shared papers)Gijs Verheijden (7 shared papers)Miranda M.C. van der Lee (3 shared papers)Patrick H. Beusker (6 shared papers)James Bristow (1 shared paper)William A. Carey (1 shared paper)
Journals: Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Cell and Tissue Research (2 papers)Connective Tissue Research (2 papers)Bioanalysis (2 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

David Egging

22 papers receiving 695 citations

Peers

Countries citing papers authored by David Egging

Since Specialization

Citations

This map shows the geographic impact of David Egging's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Egging with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Egging more than expected).

Fields of papers citing papers by David Egging

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Egging. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Egging. The network helps show where David Egging may publish in the future.

Co-authors

The 25 scholars most cited alongside David Egging, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Egging Line = papers co-authored together David Egging links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody–Drug Conjugate SYD985 Molecular Pharmaceutics ·Ronald C. Elgersma, Ruud G. E. Coumans, Tijl Huijbregts, Wiro M. P. B. Menge, John Joosten, Henri Spijker, Franciscus M. H. de Groot, Miranda M.C. van der Lee, Ruud Ubink, Diels J. van den Dobbelsteen, David Egging, Wim H.A. Dokter, Gijs Verheijden, Jacques Lemmens, C. Marco Timmers, Patrick H. Beusker	2015	163
2	The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers Molecular Cancer Therapeutics ·Miranda M.C. van der Lee, Patrick G. Groothuis, Ruud Ubink, Monique A.J. van der Vleuten, Tanja A. van Achterberg, Eline M. Loosveld, Désirée Damming, Daniëlle C.H. Jacobs, Myrthe Rouwette, David Egging, Diels van den Dobbelsteen, Patrick H. Beusker, Peter Goedings, Gijs Verheijden, Jacques Lemmens, Marco Timmers, Wim H.A. Dokter	2015	141
3	Tenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome American Journal of Medical Genetics Part C Seminars in Medical Genetics ·James Bristow, William A. Carey, David Egging, Joost Schalkwijk	2005	76
4	Interactions of human tenascin-X domains with dermal extracellular matrix molecules Archives of Dermatological Research ·David Egging, Franka van den Berkmortel, Glen Taylor, Jim Bristow, Joost Schalkwijk	2006	49
5	Wound Healing in Tenascin-X Deficient Mice Suggests that Tenascin-X is Involved in Matrix Maturation Rather than Matrix Deposition Connective Tissue Research ·David Egging, Ivonne van Vlijmen‐Willems, Tomas van Tongeren, Joost Schalkwijk, A. C. T. M. Peeters	2007	46
6	A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA mAbs ·Gerard Rouwendal, Miranda MC van der Lee, Saskia Meyer, Karli R. Reiding, Jan Schouten, Guy de Roo, David Egging, Jeanette H.W. Leusen, Péter Boross, Manfred Wuhrer, Gijs Verheijden, Wim H.A. Dokter, Marco Timmers, Ruud Ubink	2015	41
7	Unraveling the Interaction between Carboxylesterase 1c and the Antibody–Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice Molecular Cancer Therapeutics ·Ruud Ubink, Eef H.C. Dirksen, Myrthe Rouwette, Ebo Bos, I. Janssen, David Egging, Eline M. Loosveld, Tanja A. van Achterberg, Kim Berentsen, Miranda M.C. van der Lee, Francis Bichat, Olivier Raguin, Monique A.J. van der Vleuten, Patrick G. Groothuis, Wim H.A. Dokter	2018	28
8	Dermal connective tissue development in mice: an essential role for tenascin-X Cell and Tissue Research ·David Egging, I. van Vlijmen, Barry Starcher, Y. Gijsen, M.C. Zweers, Leendert Blankevoort, Jim Bristow, Joost Schalkwijk	2005	25
9	Mild Muscular Features in Tenascin-X Knockout Mice, A Model of Ehlers–Danlos Syndrome Connective Tissue Research ·Nicol C. Voermans, Kiek Verrijp, L. Eshuis, Monique C.M. Balemans, David Egging, Ellen Sterrenburg, Iris A.L.M. van Rooij, Jeroen van der Laak, Joost Schalkwijk, Silvère M. van der Maarel, Martin Lammens, Baziel G.M. van Engelen	2011	24
10	Rapid screening of IgG quality attributes – effects on Fc receptor binding FEBS Open Bio ·Karin P. M. Geuijen, Cindy Oppers‐Tiemissen, David Egging, Peter J. Simons, Louis Boon, Richard B. M. Schasfoort, Michel H. M. Eppink	2017	22
11	Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice Cell and Tissue Research ·David Egging, Ivonne van Vlijmen‐Willems, Ji-Won Choi, A. C. T. M. Peeters, Desiree van Rens, Guido Veit, Manuel Koch, Elaine C. Davis, Joost Schalkwijk	2008	21
12	Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results Multiple Sclerosis Journal ·Krzysztof Selmaj, Frederik Barkhof, Anna N Belova, Christian Wolf, Evelyn RW van den Tweel, Janine Oberyé, R. J. Mulder, David Egging, N.P. Koper, Jeffrey A. Cohen, (unknown)	2017	19
13	A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X. PubMed ·A. C. T. M. Peeters, Martina Kucharekova, Jean‐Pierre Timmermans, Franchette W.P.J. van den Berkmortel, G. H. J. Boers, I.R.O. Nováková, David Egging, Martin den Heijer, Joost Schalkwijk	2004	18
14	Identification and characterization of multiple species of tenascin‐X in human serum FEBS Journal ·David Egging, A. C. T. M. Peeters, Nicolaï Grebenchtchikov, Anneke Geurts‐Moespot, Fred C.G.J. Sweep, Martin den Heijer, Joost Schalkwijk	2007	13
15	Feedback from the European Bioanalysis Forum: Focus Workshop on Current Analysis of Immunogenicity: Best Practices and Regulatory Hurdles Bioanalysis ·Joanne Goodman, Simon Cowen, Viswanath Devanarayan, David Egging, Thomas Emrich, Michaela Golob, Daniel Kramer, Jim McNally, James D Munday, Robert Nelson, João Pedras-Vasconcelos, Timo Piironen, Denise Sickert, Venke Skibeli, Marianne Scheel Fjording, Philip Timmerman	2018	9
16	Toward clinical development of SYD985, a novel HER2-targeting antibody-drug conjugate (ADC). Journal of Clinical Oncology ·Gijs Verheijden, Patrick H. Beusker, Ruud Ubink, Miranda van der Lee, Patrick G. Groothuis, Peter Goedings, David Egging, Ellen Mattaar, Macro Timmers, Wim H.A. Dokter	2014	9
17	Sensitivity and Drug Tolerance of Antidrug Antibody Assays in Relation to Positive Control Characteristics Bioanalysis ·David Egging, Jos Verhagen, Karin de Laat-Arts, Benny de Wit, Tinie van Boekel, Marijn Buurman, Jochem Eigenhuijsen, Karin P. M. Geuijen, R. J. Mulder	2018	8
18	Rapid Buffer and Ligand Screening for Affinity Chromatography by Multiplexed Surface Plasmon Resonance Imaging Biotechnology Journal ·Karin P. M. Geuijen, Daniëlle E. J. W. van Wijk‐Basten, David Egging, Richard B. M. Schasfoort, Michel H. M. Eppink	2017	5
19	Characterization of low affinity Fcγ receptor biotinylation under controlled reaction conditions by mass spectrometry and ligand binding analysis Protein Science ·Karin P. M. Geuijen, David Egging, Stefanie J. J. Bartels, Jan Schouten, Richard B. M. Schasfoort, Michel H. M. Eppink	2016	3
20	Abstract 2651: Impressive efficacy and safety profile of a novel generation duocarmycin-based HER2-targeting ADC Cancer Research ·Willem Dokter, Ruud Ubink, Miranda van der Lee, Monique van der Vleuten, Tanja van Achterberg, Daniëlle C.H. Jacobs, Diels van den Dobbelsteen, David Egging, Ellen Mattaar, Patrick G. Groothuis, Patrick H. Beusker, Ruud G. E. Coumans, Ronald C. Elgersma, Michel H. M. Eppink, Guy de Roo, Gijs Verheijden, Marco Timmers	2014	1

About David Egging

David Egging is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging, Orthopedics and Sports Medicine, Oncology and Genetics, having authored 22 papers that have together received 723 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Connective tissue disorders research (7 papers), HER2/EGFR in Cancer Research (7 papers), Cell Adhesion Molecules Research (4 papers), Advanced Biosensing Techniques and Applications (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Tendon Structure and Treatment (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Immunology and Allergy (96 citations), Radiology, Nuclear Medicine and Imaging (322 citations), Oncology (312 citations), Genetics (152 citations) and Cell Biology (82 citations). David Egging has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Joost Schalkwijk, Wim H.A. Dokter, Ruud Ubink, Gijs Verheijden, Miranda M.C. van der Lee, Patrick H. Beusker, James Bristow, William A. Carey, Jacques Lemmens and A. C. T. M. Peeters. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Cell and Tissue Research, Connective Tissue Research and Bioanalysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact